These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27456080)

  • 1. Predicting prolonged dose titration in patients starting warfarin.
    Finkelman BS; French B; Bershaw L; Brensinger CM; Streiff MB; Epstein AE; Kimmel SE
    Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1228-1235. PubMed ID: 27456080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting time to maintenance dose in patients initiating warfarin.
    Finkelman BS; French B; Bershaw L; Kimmel SE
    Pharmacoepidemiol Drug Saf; 2015 Mar; 24(3):228-36. PubMed ID: 25504915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a proposed warfarin dosing algorithm based on the genetic make-up of Egyptian patients.
    Ekladious SM; Issac MS; El-Atty Sharaf SA; Abou-Youssef HS
    Mol Diagn Ther; 2013 Dec; 17(6):381-90. PubMed ID: 23839801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the warfarin dose with a pharmacogenetic refinement algorithm in Chinese patients mainly under low-intensity warfarin anticoagulation.
    Xu Q; Xu B; Zhang Y; Yang J; Gao L; Zhang Y; Wang H; Lu C; Zhao Y; Yin T
    Thromb Haemost; 2012 Dec; 108(6):1132-40. PubMed ID: 23015069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?
    Le Gal G; Carrier M; Tierney S; Majeed H; Rodger M; Wells PS
    J Thromb Haemost; 2010 Jan; 8(1):90-4. PubMed ID: 19874475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of pharmacogenetic algorithms and warfarin dosing table in Egyptian patients.
    Bazan NS; Sabry NA; Rizk A; Mokhtar S; Badary O
    Int J Clin Pharm; 2012 Dec; 34(6):837-44. PubMed ID: 22851439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective validation of the International Warfarin Pharmacogenetics Consortium algorithm in high-risk elderly people (VIALE study).
    Filippelli A; Signoriello S; Bancone C; Corbi G; Manzo V; Iesu S; Politi C; Gigantino A; De Donato MT; Masiello P; Simeon V; Della Corte A; Cellurale M; Conti V; Frigino M; Ciarambino T; Marracino M; Carpenito L; Ferrara N; De Feo M; Gallo C
    Pharmacogenomics J; 2020 Jun; 20(3):451-461. PubMed ID: 31801992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care.
    Gorst-Rasmussen A; Lip GY; Bjerregaard Larsen T
    Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1236-1244. PubMed ID: 27229855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of adequate use of warfarin for the elderly using decision tree-based approaches.
    Liu KE; Lo CL; Hu YH
    Methods Inf Med; 2014; 53(1):47-53. PubMed ID: 24136011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal initial dose adjustment of warfarin in orthopedic patients.
    Lenzini PA; Grice GR; Milligan PE; Gatchel SK; Deych E; Eby CS; Burnett RS; Clohisy JC; Barrack RL; Gage BF
    Ann Pharmacother; 2007 Nov; 41(11):1798-804. PubMed ID: 17911206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin.
    Gage BF; Eby C; Johnson JA; Deych E; Rieder MJ; Ridker PM; Milligan PE; Grice G; Lenzini P; Rettie AE; Aquilante CL; Grosso L; Marsh S; Langaee T; Farnett LE; Voora D; Veenstra DL; Glynn RJ; Barrett A; McLeod HL
    Clin Pharmacol Ther; 2008 Sep; 84(3):326-31. PubMed ID: 18305455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prediction Model of Warfarin Individual Maintenance Dose for Patients Undergoing Heart Valve Replacement, Based on the Back Propagation Neural Network.
    Li Q; Wang J; Tao H; Zhou Q; Chen J; Fu B; Qin W; Li D; Hou J; Chen J; Zhang WH
    Clin Drug Investig; 2020 Jan; 40(1):41-53. PubMed ID: 31586305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new regimen for starting warfarin therapy in out-patients.
    Oates A; Jackson PR; Austin CA; Channer KS
    Br J Clin Pharmacol; 1998 Aug; 46(2):157-61. PubMed ID: 9723825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Kidney Transplant Status on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage.
    Yanik MV; Irvin MR; Beasley TM; Jacobson PA; Julian BA; Limdi NA
    Pharmacotherapy; 2017 Nov; 37(11):1366-1373. PubMed ID: 28949423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study.
    Perreault S; Shahabi P; Côté R; Dumas S; Rouleau-Mailloux É; Feroz Zada Y; Provost S; Mongrain I; Dorais M; Huynh T; Kouz S; Diaz A; Blostein M; de Denus S; Turgeon J; Ginsberg J; Lelorier J; Lalonde L; Busque L; Kassis J; Talajic M; Tardif JC; Dubé MP
    Clin Cardiol; 2018 May; 41(5):576-585. PubMed ID: 29542828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administrative claims analysis of the relationship between warfarin use and risk of hemorrhage including drug-drug and drug-disease interactions.
    Zhang K; Young C; Berger J
    J Manag Care Pharm; 2006 Oct; 12(8):640-8. PubMed ID: 17269842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of the warfarin dose with clinical and pharmacogenetic data.
    ; Klein TE; Altman RB; Eriksson N; Gage BF; Kimmel SE; Lee MT; Limdi NA; Page D; Roden DM; Wagner MJ; Caldwell MD; Johnson JA
    N Engl J Med; 2009 Feb; 360(8):753-64. PubMed ID: 19228618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients.
    Huang SW; Chen HS; Wang XQ; Huang L; Xu DL; Hu XJ; Huang ZH; He Y; Chen KM; Xiang DK; Zou XM; Li Q; Ma LQ; Wang HF; Chen BL; Li L; Jia YK; Xu XM
    Pharmacogenet Genomics; 2009 Mar; 19(3):226-34. PubMed ID: 19177029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative performance of pharmacogenetics-based warfarin dosing algorithms derived from Caucasian, Asian, and mixed races in Thai population.
    Chumnumwat S; Yi K; Lucksiri A; Nosoongnoen W; Chindavijak B; Chulavatnatol S; Sarapakdi A; Nathisuwan S
    Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29243335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of sensitivity to warfarin based on VKORC1 and CYP2C9 polymorphisms in patients from different places in Colombia.
    Cifuentes RA; Murillo-Rojas J; Avella-Vargas E
    Biomedica; 2016 Mar; 36(1):91-100. PubMed ID: 27622442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.